How search interest in research compounds is shifting by country - Google Trends-grounded reports on the GLP-1 surge and the wider peptide wave in the UK, USA, Australia and beyond. Framed strictly as search-interest data, not health claims, demand forecasts or any endorsement of human use. Research use only.
6 articles tagged “Market & Search Trends”
US search interest in retatrutide ("reta", LY3437943) has gone from near-zero to a Google Trends Breakout term since 2023. What is driving the surge, what the data does and does not mean, and how US researchers source it. Search-interest data only - research use only.
UK search interest in research peptides - GLP-1 compounds, BPC-157, GHK-Cu and more - has climbed sharply since 2023. What UK researchers search for, why, the MHRA framing, and how the research-use market works. Search-interest data only - research use only.
US search interest in research peptides surged through the GLP-1 era and the FDA compounding shake-up. What American researchers search for, why, the FDA framing, and how the research-use market works. Search-interest data only - research use only.
Australian search interest in research peptides has climbed sharply, led by GLP-1 compounds. What Australian researchers search for, why, the TGA framing, and how the research-use market works. Search-interest data only - research use only.
UK search interest in retatrutide ("reta") has climbed from near-zero to a Google Trends Breakout term since 2023. What is driving the UK surge, the MHRA framing, and how UK researchers source it. Search-interest data only - research use only.
US search interest in tirzepatide ("tirz", Mounjaro, Zepbound) climbed steeply from 2022. The search arc, why an FDA-approved drug also drives research-compound interest, and the framing that matters. Search-interest data only - research use only.
Research use only. These articles summarise public literature and catalogue facts. They do not diagnose, treat, or prevent any disease, and are not medical advice.